Angiotensin converting enzyme 2 level and its significance in COVID-19 and other diseases patients.

Kamthe, Dipanjali Dhananjay; Sarangkar, Swapnil Dilip; Dalvi, Manali Suresh; Gosavi, Netra Arun; Nikam, Vandana Sandeep

Kamthe, Dipanjali Dhananjay; Sarangkar, Swapnil Dilip; Dalvi, Manali Suresh; Gosavi, Netra Arun; Nikam, Vandana Sandeep.

Afiliación

Kamthe DD; Department of Pharmacology, STES's, Smt. Kashibai Navale College of Pharmacy, Savitribai Phule Pune University, Pune, India.
Sarangkar SD; Department of Pharmacology, STES's, Smt. Kashibai Navale College of Pharmacy, Savitribai Phule Pune University, Pune, India.
Dalvi MS; Department of Pharmacology, STES's, Smt. Kashibai Navale College of Pharmacy, Savitribai Phule Pune University, Pune, India.
Gosavi NA; Department of Pharmacology, STES's, Smt. Kashibai Navale College of Pharmacy, Savitribai Phule Pune University, Pune, India.
Nikam VS; Department of Pharmacology, STES's, Smt. Kashibai Navale College of Pharmacy, Savitribai Phule Pune University, Pune, India.

Eur J Clin Invest ; 53(1): e13891, 2023 Jan.

Article en En | MEDLINE | ID: mdl-36222740

Asunto(s)

Enzima Convertidora de Angiotensina 2; COVID-19; Humanos; Enzima Convertidora de Angiotensina 2/metabolismo; Sistema Renina-Angiotensina; SARS-CoV-2/metabolismo

Palabras clave

RAS; SARS-CoV2; cardiovascular diseases; membrane-bound ACE2; soluble ACE2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enzima Convertidora de Angiotensina 2 / COVID-19 Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Eur J Clin Invest Año: 2023 Tipo del documento: Article País de afiliación: India Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google